RACGP News, 20 Feb 2019 The Lancet Oncology modelling study found 149 of 181 countries could cut rates of the preventable cancer to four per 100,000 women by the end of the century – the threshold for considering it eliminated as a public health problem. The study finds that combining high uptake of the vaccine with high screening could prevent up to 13.4 million cases of cervical cancer within...
SHINE SA, August 2018 SHINE SA is proud to present our pilot Clinical Education Forum recording. This recording is available free of charge, and access is limited to three months only. Topic: Cervical Screening Update Presenters: Megan van Zanten & Dr Amy Moten The forum ensures your knowledge of the National Cervical Screening Renewed Guidelines is accurate and in line with best practice...
Positive Life in partnership with Femfatales, the National Network of Women Living with HIV, 2018 All women and anyone with a cervix in Australia, both HIV-positive and HIV-negative, are invited to take an online, anonymous survey about awareness of HPV and related cancers. Positive Life NSW in partnership with Femfatales, the National Network of Women Living with HIV, has developed a survey to...
AJP, 9th Oct 2017
The Government has announced free access for young people to the improved HPV vaccine.
From 2018, Gardasil 9, which protects against nine HPV strains (up from four) will be offered through school-based immunisation programs to all 12 to 13-year-old boys, and girls in years seven or eight.
Read more of Gardasil 9 now on the National Immunisation Program
Australian Institute of Health and Welfare, 2017 Immunisation against the highly contagious human papillomavirus (HPV) can prevent cervical and other cancers, and other HPV-related diseases. The National HPV Vaccination Program has been immunising adolescent girls since 2007 and was extended to boys in 2013. This third Healthy Communities report on HPV immunisation shows the percentage of girls...
The Conversation, March 29, 2017 6.04am AEDT The human papillomavirus (HPV) vaccine was introduced in Australia in 2007 and New Zealand in 2008 to prevent cervical cancer. It was free for women up to age 26 in Australia and to all women under 20 in New Zealand. This is because 99.7% of cervical cancers are associated with the sexually transmissible infection. There is mounting evidence the HPV...